Industry reports
Editor highlights

Publication dates

All regions

Clinical Trial Research Reports, April 2014

You might be interested in: medical equipment, therapeutics, drug, more »


 

1-20 of about 2 700 reports for Clinical Trial
Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014

Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014" provides data on the ...

Calzada Limited (Symbol:CZD) SWOT Analysis, Strategy, Revenues and Profits

Calzada Limited (Symbol:CZD) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

... Application of polynovo's biodegradable polymer technology. Its key strategies also include the development of novoskin btm to pilot clinical trial and support snn activities.Calzada limited key recent ...

Cryosite Limited (Symbol:CTE) SWOT Analysis, Strategy, Revenues and Profits

Cryosite Limited (Symbol:CTE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

... To the research, medical, pharmaceutical, veterinary and biotechnology industries. Its services include cord blood, clinical trial services, atcc, archival, cryobyte, and adult stem cell storage. Cryosite offers ...

Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014

Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... Information and data relating to the clinical trials on refractory acute myeloid leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...

Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014

Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... As per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides ...

Refractory Leukemia Global Clinical Trials Review, H1, 2014

Refractory Leukemia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... Leukemia global clinical trials review, h1, 2014" provides data on the refractory leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials ...

Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014

Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... To the clinical trials on refractory multiple myeloma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...

Metastatic Colorectal Cancer Global Clinical Trials Review, H1, 2014

Metastatic Colorectal Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... Relating to the clinical trials on metastatic colorectal cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...

Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H1, 2014

Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... Provides elemental information and data relating to the clinical trials on metastatic hepatocellular carcinoma (hcc). It includes an overview of the trial numbers and their recruitment status as per the site ...

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2014

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... And their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also ...

» View Public Reports

About 1 600 reports for Clinical Trial

Clinical Trial Market in Canada

  • Industry report
  • February 2013
  • 27 pages
  • by Non Governmental Organization (NGO)

» Read our Company Profiles

91 Companies for Clinical Trial

Pfizer Inc.

United States

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

Johnson and Johnson

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.